Compare DNA & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNA | RYAM |
|---|---|---|
| Founded | 2008 | 1926 |
| Country | United States | United States |
| Employees | 485 | 2325 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 599.0M | 661.8M |
| IPO Year | N/A | 2014 |
| Metric | DNA | RYAM |
|---|---|---|
| Price | $7.63 | $8.21 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 1.2M | 950.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,466,397,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.37 | $3.35 |
| 52 Week High | $17.58 | $11.85 |
| Indicator | DNA | RYAM |
|---|---|---|
| Relative Strength Index (RSI) | 35.09 | 54.89 |
| Support Level | $7.59 | $6.98 |
| Resistance Level | $10.27 | $8.80 |
| Average True Range (ATR) | 0.70 | 0.39 |
| MACD | -0.26 | 0.14 |
| Stochastic Oscillator | 1.40 | 83.13 |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.